Calculated NOK return from USD · Base (NOK Calculated)
Computed from NAV history (total return, NOK, to 13 Nov 2026)
Last NAV 29.03 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
-16.3%
YTD
-15.9%
1y
-0.9%
3y, annualised
-2.0%
5y, annualised
Fund size
484.1 m USD
Total fund AUM
Management fee
1.50%
Annual · class Standard
Ongoing charge
1.60%
Annual · class Standard
Performance fee
None
Stated by the manager
Annual cost on platforms
1.55%
Class Standard · 2 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
Launched
Mar 2015
ISIN IE00B99FTC33
BenchmarkS&P 500 (performance comparator); Russell 1000 · Growth (additional comparator)
About the fund
The fund
Polen Capital Focus U.S. Growth Fund is an actively managed US equity fund with a history going back to 2015. Its benchmarks are the S&P 500 and the Russell 1000 Growth. The management company, Polen Capital, is a privately owned American growth equity boutique founded in 1979 and headquartered in Boca Raton, Florida.
Investment philosophy
The managers build a concentrated portfolio of companies with competitive advantages and potential for sustained growth. Polen Capital works with concentrated quality-growth portfolios and long holding periods, and the same applies to the company's other strategy for global growth equities.
The managers
Daniel Davidowitz is lead portfolio manager of the Focus Growth strategy and has managed the fund since March 2013. He joined Polen Capital in 2005, after working as a research analyst at Osprey Partners and Value Line and spending five years in analytical roles in healthcare at Memorial Sloan-Kettering Cancer Center. He holds a bachelor's degree in public health from Rutgers University and an MBA from Baruch College. Damon Ficklin has been co-portfolio manager since January 2024. He leads Polen Capital's Quality Growth team and is lead portfolio manager for the company's Global Growth strategy. He joined Polen Capital in 2003 as a research analyst, after working as an equity analyst covering healthcare at Morningstar. Both therefore have backgrounds as healthcare analysts.
The portfolio
The fund has fluctuated more than comparable funds.
FundTelligence description · 18/10/2026
Start date not confirmed — not ranked
Portfolio managers
DA
Portfolio Manager
On the fund since 1 Jan 2024
DA
Portfolio Manager
On the fund since 8 Mar 2013
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.